IMPI is a forum for UK based Information Managers in the pharmaceutical, healthcare and medical device industries, to share, agree and resolve common issues relating to information and knowledge management.
IMPI serves as a focus group to represent industry-wide information needs to suppliers of information products and services, thus leveraging the power of the UK pharmaceutical, healthcare and medical device industries to influence appropriate product development.
IMPI members are managers responsible for information or knowledge management functions in UK based pharmaceutical, healthcare and medical device research and development companies. Each company will normally have one member. Members are encouraged to invite colleagues to each meeting where they hold an interest in the topic to be discussed.
IMPI meets twice a year in Spring and Autumn. Each meeting addresses a 'Special Topic' with an invited expert from within the member companies or external (a vendor, academic or consultant).
Many IMPI members are also represented on the Pharma Documentation Ring (PDR), a global group with similar objectives. IMPI is thus able to represent a co-ordinated UK position to the PDR on information and knowledge management issues.
Please include "IMPI" in the subject line of the email.
The group was formed in the mid-70's by Information Managers from a number of UK R&D pharmaceutical companies who felt that a managerial level, industry specific body was required to address the challenges the profession faced at that time.
Founder companies - Beecham, ICI, May & Baker, Pfizer, SmithKline and Wellcome established the primary objectives of the group:
• To facilitate dialogue with commercial vendors to ensure that their products match the needs of the industry
• To encourage the development of the R & D pharmaceutical information profession
• To achieve these goals it was recognised that membership should be corporate and not personal.
By the end of 1980 the founder companies, had been joined by Boots, Reckitt & Colman, Glaxo, Fisons and Syntex bringing the membership to 11 companies.
The membership has continued to change reflecting the development of the UK pharmaceutical industry. Mergers and acquisitions have introduced new companies as has the developement of biotechnology companies however the objectives of the group remains the same.
As of 2016, membership stands at 10 companies.
IMPI meets twice a year, usually in March and September, with members arranging agendas and chairing meetings in rotation. Each meeting is structured around a theme agreed at the previous meeting. Action points from each meeting are taken by the member due to chair the next meeting, and are distributed within two weeks of the meeting.
IMPI meetings will normally include contributions from invited guests, providing a focus for the agreed theme of the meeting. Examples of invited guests include suppliers, expert opinion leaders, information managers from non-pharmaceutical industries etc.
The IMPI organisation operates with an open and relatively informal approach, which encourages all members to contribute and to share experience for the common good. The requirements of company confidentiality are always respected.
The next meeting will take place on 12th October 2016 at AstraZeneca Academy House, Cambridge.
General themes from previous meetings have included:
The Changing Roles of Information Professionals
Pipeline Databases Data Quality
Social Media Tools
Electronic Journal/Library Management and Mobile Technology
PDF searching and management
We offer a co-ordinated UK position and are interested, for the mutual benefit of the industry, in the following topics:
• Influencing product development via feedback
• Opportunities for professional development
• New information related technologies
• New data sources
• Strategic presentations
• Share, agree and resolve common information & knowledge management issues
Please contact us if you would like to present something that you think would interest us at one of our meetings.
We do not welcome sales pitches.
Membership is open to pharmaceutical, healthcare and medical device companies with UK based R&D facilities.
Currently, the following companies are represented:
IMPI would welcome interest from other managers in pharmaceutical, medical device & healthcare sectors and also from managers in related areas who feel they might benefit from membership.